These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 9788402)

  • 1. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI).
    Trotti A; Johnson DJ; Gwede C; Casey L; Sauder B; Cantor A; Pearlman J
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):257-61. PubMed ID: 9788402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life measurement in patients undergoing radiation therapy for head and neck cancer: a Hong Kong experience.
    Lo PS; Lo SK; Tong MC; Ku PK; Leung SF; van Hasselt CA
    J Oncol Manag; 2004; 13(6):13-23. PubMed ID: 15648221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of quality of life in head and neck cancer patients utilizing the quality of life radiation therapy questionnaire.
    Janda M; Johnson D; Woelfl H; Trimmel M; Bressmann T; Schröckmayr H; Widder J; Trotti A
    Strahlenther Onkol; 2002 Mar; 178(3):153-8. PubMed ID: 11962192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical investigation: Reliability and validity of the Japanese version of quality of life radiation therapy instrument (QOL-RTI) for Japanese patients with head and neck malignancies.
    Karasawa K; Sasaki T; Okawa T; Takahashi T; Hayakawa K; Ohizumi Y; Tamaki Y; Makino M; Kobyashi M; Shibayama C; Saitou T; Johnson DJ
    J Oncol Manag; 2003; 12(2):18-24. PubMed ID: 12699112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation and validation of the Chinese version of the Quality OF Life Radiation Therapy Instrument and the Head & Neck Module (QOL-RTI/H&N).
    Chen XL; Qiu ZW; Gu MF; Su Y; Liu LZ; Liu Y; Mo CW; Xu Q; Sun J; Li DH
    Health Qual Life Outcomes; 2014 Apr; 12():51. PubMed ID: 24731442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
    Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of radiation-induced xerostomia: validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients.
    Pellegrino F; Groff E; Bastiani L; Fattori B; Sotti G
    Support Care Cancer; 2015 Apr; 23(4):925-32. PubMed ID: 25236164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and validation of EORTC QLQ-H&N 35 into Moroccan Arabic for ENT head and neck cancer patients in Morocco.
    Ouattassi N; Benmansour N; ElFakir S; Nejjari C; Alami MN
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2727-34. PubMed ID: 26506999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.
    Fisher J; Scott C; Scarantino CW; Leveque FG; White RL; Rotman M; Hodson DI; Meredith RF; Foote R; Bachman DG; Lee N
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):832-6. PubMed ID: 12788192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
    Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
    Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
    J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity and reliability of the Turkish version of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer.
    Senkal HA; Hayran M; Karakaya E; Yueh B; Weymuller EA; Hoşal AŞ
    Am J Otolaryngol; 2012; 33(4):417-26. PubMed ID: 22137146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the functional assessment of cancer therapy nasopharyngeal cancer subscale.
    Tong MC; Lo PS; Wong KH; Yeung RM; van Hasselt CA; Eremenco S; Cella D
    Head Neck; 2009 Jun; 31(6):738-47. PubMed ID: 19260135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification.
    Pugh SL; Wyatt G; Wong RK; Sagar SM; Yueh B; Singh AK; Yao M; Nguyen-Tan PF; Yom SS; Cardinale FS; Sultanem K; Hodson DI; Krempl GA; Chavez A; Yeh AM; Bruner DW
    J Pain Symptom Manage; 2017 Jan; 53(1):139-145.e2. PubMed ID: 27899312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
    Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.
    Tribius S; Raguse M; Voigt C; Münscher A; Gröbe A; Petersen C; Krüll A; Bergelt C; Singer S
    Strahlenther Onkol; 2015 Jun; 191(6):501-10. PubMed ID: 25747264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6).
    Ringash J; Waldron JN; Siu LL; Martino R; Winquist E; Wright JR; Nabid A; Hay JH; Hammond A; Sultanem K; Hotte S; Leong C; El-Gayed AA; Naz F; Ramchandar K; Owen TE; Montenegro A; O'Sullivan B; Chen BE; Parulekar WR
    Eur J Cancer; 2017 Feb; 72():192-199. PubMed ID: 28040660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of radiotherapy on taste sensation in head and neck cancer patients - a prospective study.
    Asif M; Moore A; Yarom N; Popovtzer A
    Radiat Oncol; 2020 Jun; 15(1):144. PubMed ID: 32503643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
    Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D
    Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.